243 related articles for article (PubMed ID: 9811702)
1. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
Laquerre S; Anderson DB; Stolz DB; Glorioso JC
J Virol; 1998 Dec; 72(12):9683-97. PubMed ID: 9811702
[TBL] [Abstract][Full Text] [Related]
2. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
Laquerre S; Argnani R; Anderson DB; Zucchini S; Manservigi R; Glorioso JC
J Virol; 1998 Jul; 72(7):6119-30. PubMed ID: 9621076
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
[TBL] [Abstract][Full Text] [Related]
5. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein.
Wang X; Kong L; Zhang GR; Sun M; Geller AI
Brain Res Mol Brain Res; 2005 Sep; 139(1):88-102. PubMed ID: 15993510
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
8. HSV-1 virions engineered for specific binding to cell surface receptors.
Grandi P; Wang S; Schuback D; Krasnykh V; Spear M; Curiel DT; Manservigi R; Breakefield XO
Mol Ther; 2004 Mar; 9(3):419-27. PubMed ID: 15006609
[TBL] [Abstract][Full Text] [Related]
9. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread.
Cheshenko N; Herold BC
J Gen Virol; 2002 Sep; 83(Pt 9):2247-2255. PubMed ID: 12185280
[TBL] [Abstract][Full Text] [Related]
11. The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes.
Musarrat F; Jambunathan N; Rider PJF; Chouljenko VN; Kousoulas KG
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321326
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutations in the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B on intracellular transport and infectivity.
Beitia Ortiz de Zarate I; Kaelin K; Rozenberg F
J Virol; 2004 Feb; 78(3):1540-51. PubMed ID: 14722308
[TBL] [Abstract][Full Text] [Related]
13. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
14. Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator.
Rux AH; Willis SH; Nicola AV; Hou W; Peng C; Lou H; Cohen GH; Eisenberg RJ
J Virol; 1998 Sep; 72(9):7091-8. PubMed ID: 9696802
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 gK is required for gB-mediated virus-induced cell fusion, while neither gB and gK nor gB and UL20p function redundantly in virion de-envelopment.
Melancon JM; Luna RE; Foster TP; Kousoulas KG
J Virol; 2005 Jan; 79(1):299-313. PubMed ID: 15596825
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
17. Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells.
Grandi P; Fernandez J; Szentirmai O; Carter R; Gianni D; Sena-Esteves M; Breakefield XO
Cancer Gene Ther; 2010 Sep; 17(9):655-63. PubMed ID: 20508670
[TBL] [Abstract][Full Text] [Related]
18. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors.
Tsitoura E; Lucas M; Revol-Guyot V; Epstein AL; Manservigi R; Mavromara P
J Gen Virol; 2002 Mar; 83(Pt 3):561-566. PubMed ID: 11842251
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
